Adimab, LLC's Net Worth
$127 Million
Who is Adimab, LLC?
Adimab, LLC has an estimated net worth of $127 Million. This is based on reported shares in Adagio Therapeutics, Inc..
SEC CIK
Adimab, LLC's CIK is 0001545672
Past Insider Trading and Trends
2021 was Adimab, LLC's most active year for acquiring shares with 1 total transactions. Adimab, LLC's most active month to acquire stocks was the month of July. 2021 was Adimab, LLC's most active year for disposing of shares, totalling 3 transactions. Adimab, LLC's most active month to dispose stocks was the month of July. 2021 saw Adimab, LLC paying a total of $0.00 for 25,860,700 shares, this is the most they've acquired in one year. In 2021 Adimab, LLC cashed out on 5,172,140 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Invivyd, Inc. (IVVD) Snapshot price: $4.755
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -18.74% | -5.00M |
$3.95 | -$19,750,000.00 | 21.69M |
Jan 19
| |||
Form 4
| -4.16% | -1.16M |
—
|
—
| 26.69M |
Mar 3
| |||
Form 4
| +1,302.61% | 25.86M |
—
|
—
| 27.85M |
Aug 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||